Esophageal Neoplasms: all 1,631 studies
Page 4 of 17. Open to participants first (469), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06043466Phase 1
- CPAP for Esophageal Cancer With RadiotherapyRecruitingNCT06037902Not applicable
- Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA SequencingRecruitingNCT06036563
- Endoscopic Submucosal Dissection RegistryRecruitingNCT06033976
- Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albuminEnrolling by invitationNCT06030934Phase 2
- Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction CancerRecruitingNCT06028737Phase 2/3
- Submucosal Saline Injection Followed by Endoscopic UltrasoundRecruitingNCT06022978Not applicable
- The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.RecruitingNCT06019455
- Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)Not yet recruitingNCT06012318
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsRecruitingNCT06010862Phase 1
- Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal CancerRecruitingNCT06009705
- A Study of SI-B003, BL-B01D1+SI-B003 and BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Esophageal Cancer, Gastric Cancer, Colorectal Cancer and Other Gastrointestinal TumorsRecruitingNCT06008054Phase 2
- Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNot yet recruitingNCT05996484Phase 2
- Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION)RecruitingNCT05996276
- Neoadjuvant Toripalimab for dMMR/MSI-H Gastric CancerRecruitingNCT05994456Phase 2
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsRecruitingNCT05983432Phase 1
- Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell CarcinomaRecruitingNCT05978193Phase 2
- The Effect of Chronic Stress on Efficacy of ICIs in Esophageal Cancer Patients (STRESS-ESCA Study)RecruitingNCT05967910
- Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT05960955Phase 2
- Supercharged TRAM Evaluation in Cervical Esophagogastroplasty After EsophagectomyRecruitingNCT05954702Not applicable
- Minimally Residual of Esophageal Cancer 001RecruitingNCT05952661
- HTL0039732 in Participants With Advanced Solid TumoursRecruitingNCT05944237Phase 1/2
- Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal CarcinomaRecruitingNCT05937438Phase 1/2
- Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With CancerRecruitingNCT05875870Not applicable
- Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal CancerRecruitingNCT05866510Phase 2
- A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)RecruitingNCT05865002Phase 1
- A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal TumorsNot yet recruitingNCT05856500Not applicable
- Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer PatientsRecruitingNCT05850130Not applicable
- Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical ResearchNot yet recruitingNCT05831150
- A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid TumorsRecruitingNCT05830097Phase 1/2
- The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1RecruitingNCT05829057Phase 1
- A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/RadiotherapyNot yet recruitingNCT05828875
- Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal CancerNot yet recruitingNCT05828381Phase 2
- Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal CarcinomaNot yet recruitingNCT05821452Phase 2
- Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy StrategyRecruitingNCT05817201Phase 2/3
- The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection StudyRecruitingNCT05804331
- Acupuncture Effect on Dumping Syndrome in Esophagus Cancer Patients With Feeding JejunostomyRecruitingNCT05801666Not applicable
- Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal CancerRecruitingNCT05800054Not applicable
- Individualized Dose Escalation of 5-FU for Gastrointestinal CancerRecruitingNCT05780684Not applicable
- PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID TrialRecruitingNCT05775939Not applicable
- Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal NeoplasiaRecruitingNCT05768282Phase 4
- An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell CarcinomaNot yet recruitingNCT05759325
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsRecruitingNCT05733000Phase 2
- Retrospective Review of Esophageal Cancer at MSKCCRecruitingNCT05706558
- Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal CancerEnrolling by invitationNCT05706025Not applicable
- Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerRecruitingNCT05705492Phase 2
- Liquid Biopsies in Esophageal CancerRecruitingNCT05704530Not applicable
- Rehabilitation and Recovery for Persons With Esophageal or Gastric CancerRecruitingNCT05698992
- Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based BiomarkersRecruitingNCT05688176
- Tranexamic Acid During Upper GI Endoscopic Resection ProceduresRecruitingNCT05688020Phase 4
- REVOLUTION Surgery (REVOLUTION Surgery)RecruitingNCT05642819
- Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell CarcinomaRecruitingNCT05637268Phase 2
- Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal CancerNot yet recruitingNCT05628610Phase 2
- Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.RecruitingNCT05624099Phase 2
- [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid TumorsRecruitingNCT05619016Phase 2
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in HumansRecruitingNCT05591053Not applicable
- The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal CancerRecruitingNCT05547529Phase 3
- Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision RadiotherapyRecruitingNCT05543057
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionRecruitingNCT05517811
- Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell CarcinomaRecruitingNCT05515315Phase 2
- Perioperative Analgesia Modes in Minimally Invasive EsophagectomyRecruitingNCT05504265Phase 2/3
- Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)RecruitingNCT05443841
- Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced GastricNot yet recruitingNCT05387681Phase 2
- To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for RecurrenceRecruitingNCT05376423Phase 2
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)RecruitingNCT05357846Phase 3
- Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric JunctionRecruitingNCT05356520Not applicable
- Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal CancerRecruitingNCT05349045
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)RecruitingNCT05332002Phase 2
- Surgery or Chemoradiotherapy for Cervical Esophageal CancerRecruitingNCT05327517Not applicable
- A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)RecruitingNCT05319730Phase 1/2
- Nutritional Support During Induction Therapy for Esophageal CancerRecruitingNCT05314946Not applicable
- Evaluating Acid Reflux After Oesophageal Stenting Using Anti-reflux StentsRecruitingNCT05303298Not applicable
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- EMR Versus ESD for Barrett's NeoplasiaRecruitingNCT05276791Not applicable
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid TumorRecruitingNCT05262491Phase 1
- Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma PatientsRecruitingNCT05252078Phase 2
- Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver CancerRecruitingNCT05192460Not applicable
- CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal CancerRecruitingNCT05187182Phase 1
- A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal CancerNot yet recruitingNCT05183958Phase 2
- Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerRecruitingNCT05183126Phase 4
- Treatment Outcomes of Esophageal CancerRecruitingNCT05177393
- Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric CancerRecruitingNCT05163483Phase 2
- A Beta-only IL-2 ImmunoTherapY StudyRecruitingNCT05086692Phase 1/2
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruitingNCT05059444
- PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyRecruitingNCT05055648Phase 3
- Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanRecruitingNCT05005403Phase 1
- AB122 Platform StudyRecruitingNCT04999761Phase 1
- S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction AdenocarcinomaRecruitingNCT04989985Phase 2
- CPAP or BiPAP for Motion Mitigation During RadiotherapyRecruitingNCT04986293Not applicable
- Spanish Registry of Esophagogastric CancerRecruitingNCT04958720
- Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric JunctionRecruitingNCT04910789Not applicable
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable
- Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and RadiotherapyRecruitingNCT04892849
- Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNot yet recruitingNCT04889742Phase 2
- Surgery As Needed for Oesophageal Cancer - 2RecruitingNCT04886635
- The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage IIIRecruitingNCT04871412Phase 3